Nicergolin (Nicergoline)

Nicergoline, the active ingredient in Nicergolin, is an ergot‑derived cerebral vasodilator presented as an oral tablet. It is used to improve cerebral blood flow and neuronal metabolism in elderly patients with cognitive impairment, in vascular dementia, and in other cerebral circulatory disorders where enhanced perfusion is desired.

GNH USA supplies Nicergolin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring EU‑quality standards and reliable global distribution. The company provides full regulatory documentation and supports import logistics for institutional buyers.

Nicergolin acts on cerebral vascular function and is employed in several neurologic conditions. - Cognitive impairment in the elderly: improves cerebral perfusion and may support memory and attention functions. - Vascular dementia: helps maintain blood flow to brain regions affected by vascular injury, potentially slowing cognitive decline. - Cerebral circulatory disorders: enhances overall cerebral blood supply, aiding symptoms related to reduced perfusion.

Nicergoline may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness or vertigo: especially on standing. - Gastrointestinal upset: nausea, abdominal discomfort. - Flushing: transient skin redness. - Nasal congestion: mild blockage of nasal passages.

Serious or Rare Side Effects: - Hypotension: marked drop in blood pressure. - Cardiac arrhythmias: irregular heart rhythm. - Hepatic dysfunction: elevated liver enzymes. - Severe allergic reactions: rash, swelling, or anaphylaxis.

When prescribing Nicergolin, clinicians should consider several precautionary measures to ensure safe use. - Cardiovascular assessment: evaluate for existing hypertension or hypotension. - Liver function monitoring: check baseline hepatic enzymes. - Renal function: assess kidney status in patients with impairment. - Concomitant vasodilators: avoid additive blood‑pressure‑lowering effects. - Elderly patients: start at lower dose and monitor for dizziness. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in original container.

Nicergoline can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Antihypertensive agents: may cause excessive blood pressure reduction. - Phosphodiesterase‑5 inhibitors: increased risk of hypotension. - Other ergot derivatives: heightened risk of vasospasm and toxicity.

Moderate Interactions (Monitor Closely): - Antiplatelet or anticoagulant drugs: enhanced bleeding tendency. - CYP450 inhibitors: possible increase in Nicergoline plasma levels. - CNS depressants: may augment dizziness or sedation.